Effects of trichostatin A on HDAC8 expression, proliferation and cell cycle of Molt-4 cells

Abstract

The effects of Trichostatin A (TSA) on histone deacetylase 8 (HDAC8) expression, proliferation and cell cycle arrest in T-lymphoblastic leukemia cell line Molt-4 cells in vitro were investigated. The effect of TSA on the growth of Molt-4 cells was studied by MTT assay. Flow cytometry was used to examine the cell cycle. The expression of HDAC8 was detected by using immunocytochemistry and Western blot. The results showed that proliferation of Molt-4 cells was inhibited in TSA-treated group in a time-and dose-dependent manner. The IC50 of TSA exposures for 24 h and 36 h were 254.3236 and 199.257 μg/L respectively. The cell cycle analysis revealed that Molt-4 was mostly in G₀/G₁ phase, and after treatment with TSA from 50 to 400 μg/L for 24 h, the percents of G₀/G₁ cells were decreased and cells were arrested in G₂/M phase. Treatment of TSA for 24 h could significantly inhibit the expression of HDAC8 protein in Molt-4 cells (P<0.01). It was concluded that TSA could decrease the expression of HDAC8 in Molt-4 cells, which contributed to the inhibition of proliferation and induction of cell cycle arrest in Molt-4 cells.

Keywords

trichostain A / histone deacetylase 8 / T-lymphoblastic leukemia / Molt-4

References

[1] MonneretC.. Histone deacetylase inhibitors. Eur J Med Chem, 2005, 40: 1-13

[2] VanhaeckeT., PapeleuP., ElautG., et al.. Trichostatin A-like hydroxamate histone deacetylase inhibitors as therapeutic agents: toxicological point of view. Curr Med Chem, 2004, 11: 1629-1643

[3] VanniniA., VolpariC., FilocamoG., et al.. Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor. Proc Natl Acad Sci U S A, 2004, 101: 15 064-15 069

[4] LiuH., ChenY., CuiG., et al.. Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation effect. Acta Pharmacol Sin, 2005, 26: 603-609

[5] BuggyJ. J., SiderisM. L., MarkP., et al.. Cloning and characterization of a novel human histone deacetylase, HDAC8. Biochem J, 2000, 350: 199-205

[6] Van den WyngaertI., de VriesW., KremerA., et al.. Cloning and characterization of human histone deacetylase 8. FEBS Lett, 2000, 478: 77-83

[7] HuE., ChenZ., FredricksonT., et al.. Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor. J Biol Chem, 2000, 275: 15 254-15 264

[8] WaltregnyD., De LevalL., GlenissonW., et al.. Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues. Am J Pathol, 2004, 165: 553-564

[9] DurstK. L., LutterbachB., KummalueT., et al.. The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavy-chain domain. Mol Cell Biol, 2003, 23: 607-619

[10] ThakurA., XuH., WangY., et al.. The role of X-linked genes in breast cancer. Breast Cancer Res Treat, 2005, 93: 135-143

[11] SongY., LiuM. J., ZhaoG. W., et al.. The mechanism of P21^WAF1/Cip-1 expression in Molt-4 cell line induced by TSA (Chinese). J Exp Hematology, 2005, 13: 174-181

[12] YoshidaM., FurumaiR., NishiyamaM., et al.. Histone deacetylase as a new target for cancer chemotherapy. Cancer Chemother Pharmacol, 2001, 48(Suppl1): S20-S26